loader image
Friday, November 28, 2025
74.5 F
McAllen
- Advertisement -

Important Update on Prescription Forms for TMB and TSBP Licensees

Translate to Spanish or other 102 languages!

Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe. Image for illustration purposes
Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe. Image for illustration purposes
- Advertisement -

 By the Texas Medical Association

As many of our licensees are aware, the recent cyberattack on Change Healthcare has hampered some patients’ ability to obtain certain necessary prescription medications.    

The Texas Medical Board (TMB), in conjunction with the Texas State Board of Pharmacy (TSBP), would like to take this opportunity to remind prescribers that during times when electronic prescribing is unavailable, practitioners are able to utilize the official, physical Schedule II prescription form provided by the TSBP.  These forms may be ordered online via the TSBP’s website at www.pharmacy.texas.gov/PMP/CIIforms.asp.  

- Advertisement -

Prescribers may consider having Official (CII) Prescription Forms more readily available should there be future events that would impact the ability to e-prescribe.   

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral Hosting Webinar on Seasonal Depression, Dec. 4

Mega Doctor News It’s common for individuals to experience an emotional downturn during the winter...

AMA Adopts New Public Health Policies to Improve Health of the Nation

The American Medical Association (AMA) gathered physician and medical student leaders from all corners of medicine at its Interim Meeting of the House of Delegates to shape guiding policies on emerging health care topics.

Study Finds Best Strategy for Reducing Belly Fat

Over the last few years, research has shown that having excessive visceral fat — the fat surrounding the abdominal area that protects internal organs — can be detrimental to a person’s health.

FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy

The U.S. Food and Drug Administration approved Itvisma (onasemnogene abeparvovec-brve) for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in the survival motor neuron 1 (SMN1) gene. Itvisma is an adeno-associated virus (AAV) vector-based gene therapy.
- Advertisement -
×